Corcept Therapeutics Incorporated
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 1999 | — | $-244.0K | — |
| Dec 2000 | — | $-2.0M | — |
| Dec 2001 | — | $-7.5M | — |
| Dec 2002 | — | $-21.9M | — |
| Dec 2003 | — | $-31.5M | — |
| Dec 2004 | — | $45.9M | — |
| Dec 2005 | — | $26.6M | — |
| Dec 2006 | — | $6.4M | — |
| Dec 2007 | — | $14.7M | — |
| Dec 2008 | — | $16.9M | $14.7M |
| Dec 2009 | — | $22.1M | $23.9M |
| Jun 2010 | — | — | $35.4M |
| Sep 2010 | — | — | $29.0M |
| Dec 2010 | — | $21.2M | $24.6M |
| Mar 2011 | — | — | $59.2M |
| Jun 2011 | — | $48.9M | $52.2M |
| Sep 2011 | — | $43.7M | $45.9M |
| Dec 2011 | — | $34.8M | $39.6M |
| Mar 2012 | — | $39.3M | $42.6M |
| Jun 2012 | — | $32.8M | $34.9M |
| Sep 2012 | $28.3M | $71.7M | $101.6M |
| Dec 2012 | $29.0M | $61.8M | $93.0M |
| Mar 2013 | $28.9M | $51.0M | $81.5M |
| Jun 2013 | $30.2M | $40.4M | $72.2M |
| Sep 2013 | $30.1M | $30.8M | $63.2M |
| Dec 2013 | $29.3M | $21.0M | $54.9M |
| Mar 2014 | $28.2M | $9.4M | $43.6M |
| Jun 2014 | $27.6M | $3.5M | $34.0M |
| Sep 2014 | $26.0M | $-1.3M | $26.8M |
| Dec 2014 | $24.5M | $-3.4M | $24.2M |
| Mar 2015 | $22.1M | $10.6M | $38.0M |
| Jun 2015 | $19.4M | $11.5M | $37.0M |
| Sep 2015 | $16.1M | $13.5M | $36.5M |
| Dec 2015 | $12.5M | $18.5M | $40.4M |
| Mar 2016 | $8.7M | $20.2M | $40.7M |
| Jun 2016 | $3.7M | $25.7M | $41.8M |
| Sep 2016 | $0 | $31.2M | $47.9M |
| Dec 2016 | $0 | $41.4M | $51.5M |
| Mar 2017 | $0 | $49.6M | $38.0M |
| Jun 2017 | $0 | $66.1M | $33.6M |
| Sep 2017 | $0 | $86.3M | $31.1M |
| Dec 2017 | $0 | $191.0M | $31.1M |
| Mar 2018 | — | $215.2M | $33.1M |
| Jun 2018 | — | $243.5M | $31.2M |
| Sep 2018 | — | $259.5M | $33.9M |
| Dec 2018 | — | $275.9M | $41.6M |
| Mar 2019 | — | $285.8M | $49.7M |
| Jun 2019 | — | $298.1M | $58.1M |
| Sep 2019 | — | $334.4M | $44.9M |
| Dec 2019 | — | $371.2M | $31.3M |
| Mar 2020 | — | $409.5M | $84.5M |
| Jun 2020 | — | $453.7M | $58.5M |
| Sep 2020 | — | $489.7M | $30.6M |
| Dec 2020 | — | $523.3M | $76.2M |
| Mar 2021 | — | $510.8M | $52.4M |
| Jun 2021 | — | $522.7M | $95.4M |
| Sep 2021 | — | $540.2M | $94.7M |
| Dec 2021 | — | $375.8M | $77.6M |
| Mar 2022 | — | $407.8M | $61.9M |
| Jun 2022 | — | $442.3M | $35.3M |
| Sep 2022 | — | $473.4M | $50.2M |
| Dec 2022 | — | $501.8M | $66.3M |
| Mar 2023 | — | $529.6M | $299.9M |
| Jun 2023 | — | $421.6M | $172.4M |
| Sep 2023 | — | $461.7M | $111.8M |
| Dec 2023 | — | $506.7M | $135.6M |
| Mar 2024 | — | $547.9M | $149.8M |
| Jun 2024 | — | $596.2M | $128.6M |
| Sep 2024 | — | $638.8M | $137.3M |
| Dec 2024 | — | $679.6M | $127.7M |
| Mar 2025 | — | $683.3M | $89.8M |
| Jun 2025 | — | $635.8M | $102.7M |
| Sep 2025 | — | $631.9M | $125.1M |
| Dec 2025 | — | $647.8M | $120.5M |
| Mar 2026 | — | $638.0M | $108.7M |
| Jun 2026 | — | $705.8M | $111.0M |